NDC 71610-661

Alogliptin

Alogliptin

Alogliptin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Alogliptin Benzoate.

Product ID71610-661_7ecf7f4e-e65c-4dde-9db9-20a170a427c9
NDC71610-661
Product TypeHuman Prescription Drug
Proprietary NameAlogliptin
Generic NameAlogliptin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2016-04-08
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA022271
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameALOGLIPTIN BENZOATE
Active Ingredient Strength13 mg/1
Pharm ClassesDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71610-661-09

9000 TABLET, FILM COATED in 1 BOTTLE (71610-661-09)
Marketing Start Date2022-09-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Alogliptin" or generic name "Alogliptin"

NDCBrand NameGeneric Name
45802-087AlogliptinAlogliptin
45802-103AlogliptinAlogliptin
45802-150AlogliptinAlogliptin
50090-5574AlogliptinAlogliptin
71610-300AlogliptinAlogliptin
71610-661AlogliptinAlogliptin
64764-125Nesinaalogliptin
64764-250Nesinaalogliptin
64764-625Nesinaalogliptin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.